Physician profile
James T Good
NPI 1639135825
$5,561.95
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $78.84 · 2021: $198 · 2022: $4,218 · 2023: $37.89 · 2024: $623 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $481 · Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $481.23 |
| Food and Beverage | $317.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $4,136.44 | 2021-2022 | |
| Paragon 28, INC. | $529.90 | 2024 | Ttc Nail, Activcore Nail |
| Organogenesis INC. | $340.86 | 2019-2024 | Puraply, Affinity |
| Janssen Pharmaceuticals, INC | $131.90 | 2021 | |
| Surgenex LLC | $121.70 | 2025 | Pellograft, Surmatrix, Ardeograft |
| Stryker Corporation | $101.80 | 2019 | |
| Wright Medical Technology, INC. | $47.09 | 2020 | |
| Kci USA, INC. | $33.69 | 2019-2020 | |
| Integra Lifesciences Corporation | $32.25 | 2019-2020 | |
| Smith+Nephew, INC. | $25.82 | 2019 | |
| Derma Sciences, INC. | $18.77 | 2019 | |
| Acumed LLC | $16.19 | 2025 | Acumed, Innate Implant |
| Musculoskeletal Transplant Foundation INC. | $14.04 | 2021 | |
| Merck Sharp & Dohme LLC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$599,999.76 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.